calendar
72 catalysts · 3,827 phase readout · 2,121 8k filing · 276 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
next 91 dayslessmore
MonWedFri
72 catalysts · 3,827 phase readout · 2,121 8k filing · 276 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: MWG. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: QZH. Advisory committee: TX. Decision: APPR
Supplement type: Real-Time Process. Product code: NIK. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: NAW. Advisory committee: RA. Decision: APPR
Supplement type: 30-Day Notice. Product code: MRA. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: QPY. Advisory committee: PM. Decision: OK30
Supplement type: Real-Time Process. Product code: LWP. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track. Product code: DSQ. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Special (Immediate Track). Product code: NPW. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: QFV. Advisory committee: CV. Decision: APPR
Supplement type: Special (Immediate Track). Product code: QQK. Advisory committee: GU. Decision: APPR
Supplement type: 30-Day Notice. Product code: NJL. Advisory committee: OR. Decision: OK30
Therapy area: Dermatology. Indication: Chronic Urticaria
No description on file. Bork keeps sniffing.
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization
Therapy area: Genetic Disorders. Indication: Duchenne Muscular Dystrophy
Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion
Therapy area: Ophthalmology. Indication: Diabetic Retinopathy
Therapy area: Ophthalmology. Indication: Diabetic Macular Edema
Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.